z-logo
open-access-imgOpen Access
Pharmacogenetic Discovery in CALGB (Alliance) 90401 and Mechanistic Validation of a VAC14 Polymorphism that Increases Risk of Docetaxel-Induced Neuropathy
Author(s) -
Daniel L. Hertz,
Kouros Owzar,
Sherrie Lessans,
Claudia Wing,
Chen Jiang,
William Kevin Kelly,
Jai N. Patel,
Susan Halabi,
Yoichi Furukawa,
Heather E. Wheeler,
Alexander B. Sibley,
Cameron Lassiter,
Lois S. Weisman,
Dorothy Watson,
Stefanie D. Krens,
Flora Mulkey,
Cynthia L. Renn,
Eric J. Small,
Phillip G. Febbo,
Ivo Shterev,
Deanna L. Kroetz,
Paula N. Friedman,
John F. Mahoney,
Michael A. Carducci,
Michael Kelley,
Yusuke Nakamura,
Michiaki Kubo,
Susan G. Dorsey,
M. Eileen Dolan,
Michael J. Morris,
Mark J. Ratain,
Howard L. McLeod
Publication year - 2016
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/hk99-y662
Subject(s) - docetaxel , pharmacogenetics , medicine , pharmacology , oncology , genotype , biology , chemotherapy , genetics , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here